Home Home Home Inbox Home Search

Event

Extended Pharmacodynamic and Immunomodulatory Activity of the MAPKAP Kinase II (MK2) Inhibitor MMI-0100 Demonstrated in a Phase 1 Lipopolysaccharide (LPS) Challenge Study Conducted in Subjects Who Smoke [Board No. 909]

Location: Board no. 909
Session Type: RAPiD: Rapid Abstract Poster Discussion Session
Sunday
May
20
9:15 AM
11:15 AM
Home Home Home Inbox Home Search